How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

A full ratchet is an anti-dilution provision that adjusts the option price or conversion ratio for shareholders to the lowest sale price. Get personalized, AI-powered answers built on 27+ years of ...

The phenomenon of a Full Moon arises when our planet, Earth, is precisely sandwiched between the Sun and the Moon. This alignment ensures the entire side of the Moon that faces us gleams under ...

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.